BSACI 2021 guideline for the management of egg allergy
Research article published in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2021)
Abstract
This guideline advises on the management of patients with egg allergy. Most commonly egg allergy presents in infancy, with a prevalence of approximately 2% in children and 0.1% in adults. A clear clinical history will confirm the diagnosis in most cases. Investigation by measuring egg-specific IgE (by skin prick testing or specific IgE assay) is useful in moderate-severe cases or where there is diagnostic uncertainty. Following an acute allergic reaction, egg avoidance advice should be provided. Egg allergy usually resolves, and reintroduction can be achieved at home if reactions have been mild and there is no asthma. Patients with a history of severe reactions or asthma should have reintroduction guided by a specialist. All children with egg allergy should receive the MMR vaccine. Most adults and children with egg allergy can receive the influenza vaccine in primary care, unless they have had anaphylaxis to egg requiring intensive care support. Yellow Fever vaccines should only be considered in egg-allergic patients under the guidance of an allergy specialist. This guideline was prepared by the Standards of Care Committee (SOCC) of the British Society for Allergy and Clinical Immunology (BSACI) and is intended for allergists and others with a special interest in allergy. The recommendations are evidence based. Where evidence was lacking, consensus was reached by the panel of specialists on the committee. The document encompasses epidemiology, risk factors, diagnosis, treatment, prognosis and co-morbid associations.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Resumen
This guideline advises on the management of patients with egg allergy.
Por qué esto importa para la hirudoterapia
Esta guía de práctica clínica orienta sobre el manejo de la alergia al huevo, abarcando el diagnóstico mediante la historia clínica y la determinación de IgE específica frente al huevo, la evitación del huevo, las estrategias de reintroducción y las recomendaciones de vacunación, que incluyen la triple vírica (MMR), la gripe y la fiebre amarilla. Fue elaborada por el Comité de Normas de Atención de la Sociedad Británica de Alergia e Inmunología Clínica, dirigida a alergólogos y otros profesionales con un interés especial. El resumen aborda una afección de hipersensibilidad alimentaria y no menciona la hirudoterapia, la terapia con sanguijuelas, la hirudina, el secretoma de la sanguijuela ni temas relacionados con anticoagulantes. Por lo tanto, basándose únicamente en el resumen, no existe una relevancia defendible respecto al dominio de la hirudoterapia/secretoma de la sanguijuela de la ASH.
Citación
BSACI 2021 guideline for the management of egg allergy
Leech SC et al. · Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2021
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: 18 de junio de 2026